Abstract
We assessed the reliability, validity, and responsiveness to change of the 6-item Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI) in a sample of 615 metastatic breast cancer patients. The FBSI is a brief, clinically relevant, and psychometrically sound instrument that can be used to measure symptoms in patients with breast cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 295-298 |
Number of pages | 4 |
Journal | Breast Cancer Research and Treatment |
Volume | 90 |
Issue number | 3 |
DOIs | |
State | Published - Apr 2005 |
Funding
This work was supported by Eastern Cooperative Oncology Group grant CA 21115 E1193 and by an unrestricted grant from AstraZeneca.
Keywords
- Breast cancer
- Health-related quality of life
- Meaningful differences
- Reliability
- Symptoms
- Validity
ASJC Scopus subject areas
- Oncology
- Cancer Research